Literature DB >> 2085466

DNA-binding activity of retinoblastoma protein is intrinsic to its carboxyl-terminal region.

N P Wang1, P L Chen, S Huang, L A Donoso, W H Lee, E Y Lee.   

Abstract

The retinoblastoma (RB) gene encodes a nuclear phosphoprotein with a molecular weight of 110,000 (pp110RB) associated with DNA-binding activity. This sequence-nonspecific DNA binding activity was further studied by Southwestern and DNA-cellulose chromatography using purified fusion proteins expressed in Escherichia coli. Three fusion proteins, containing amino acids 612-775, 776-928, and 612-928 of pp110RB, bound to DNA; the binding affinity of the latter was approximately 20-fold higher than those of either smaller region. Other regions of pp110RB had no detectable binding activity, indicating that the carboxyl-terminal region of the RB protein is the major domain responsible for interacting with DNA. Since several potential phosphorylation sites reside within this region, isoforms of RB protein from cellular lysates with various degrees of phosphorylation were compared with respect to their DNA-binding affinity. The hyperphosphorylated form was eluted from DNA-cellulose columns at 0.1-0.3 M NaCl, whereas the hypophosphorylated form appeared in the eluates only at salt concentrations of 0.4-0.7 M, implying that phosphorylation of RB protein may affect its DNA-binding activity. That pp110RB can bind DNA intrinsically, and that this activity can be modulated by phosphorylation, is consistent with the proposed regulatory role of the RB protein in cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085466

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  8 in total

1.  Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F.

Authors:  B Shan; X Zhu; P L Chen; T Durfee; Y Yang; D Sharp; W H Lee
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

2.  Mutations of N-terminal regions render the retinoblastoma protein insufficient for functions in development and tumor suppression.

Authors:  D J Riley; C Y Liu; W H Lee
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

3.  Purification and characterization of a DNA-binding heterodimer of 52 and 100 kDa from HeLa cells.

Authors:  W W Zhang; L X Zhang; R K Busch; J Farrés; H Busch
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

Review 4.  Epigenetic regulatory mechanisms in vertebrate eye development and disease.

Authors:  A Cvekl; K P Mitton
Journal:  Heredity (Edinb)       Date:  2010-02-24       Impact factor: 3.821

Review 5.  RNA polymerase III repression by the retinoblastoma tumor suppressor protein.

Authors:  Alison Gjidoda; R William Henry
Journal:  Biochim Biophys Acta       Date:  2012-10-12

6.  Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.

Authors:  S M Stirdivant; H E Huber; D R Patrick; D Defeo-Jones; E M McAvoy; V M Garsky; A Oliff; D C Heimbrook
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

7.  Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.

Authors:  P S Huang; D R Patrick; G Edwards; P J Goodhart; H E Huber; L Miles; V M Garsky; A Oliff; D C Heimbrook
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

8.  The N-terminal domain of the Drosophila retinoblastoma protein Rbf1 interacts with ORC and associates with chromatin in an E2F independent manner.

Authors:  Joseph Ahlander; Xiao-Bo Chen; Giovanni Bosco
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.